Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Progyny Inc (NASDAQ: PGNY) was $24.02 for the day, down -0.54% from the previous closing price of $24.15. In other words, the price has decreased by -$0.54 from its previous closing price. On the day, 1.25 million shares were traded. PGNY stock price reached its highest trading level at $24.335 during the session, while it also had its lowest trading level at $23.82.
Ratios:
Our analysis of PGNY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.70. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On July 08, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform but kept the price unchanged to $28.
JP Morgan Downgraded its Overweight to Neutral on December 02, 2024, while the target price for the stock was maintained at $17.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’25 when Livingston Mark S. sold 213 shares for $25.50 per share. The transaction valued at 5,432 led to the insider holds 47,921 shares of the business.
Swartz Allison bought 530 shares of PGNY for $13,033 on Dec 04 ’25. On Nov 28 ’25, another insider, Swartz Allison, who serves as the EVP, GC of the company, sold 2,398 shares for $26.87 each. As a result, the insider received 64,434 and left with 73,657 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 2070803968 and an Enterprise Value of 1753746944. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.03, and their Forward P/E ratio for the next fiscal year is 25.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.63 while its Price-to-Book (P/B) ratio in mrq is 3.70. Its current Enterprise Value per Revenue stands at 1.382 whereas that against EBITDA is 19.423.
Stock Price History:
The Beta on a monthly basis for PGNY is 0.94, which has changed by 0.51641417 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $27.51, while it has fallen to a 52-week low of $13.86. The 50-Day Moving Average of the stock is 9.49%, while the 200-Day Moving Average is calculated to be 8.42%.
Shares Statistics:
PGNY traded an average of 1.56M shares per day over the past three months and 1259940 shares per day over the past ten days. A total of 86.15M shares are outstanding, with a floating share count of 71.95M. Insiders hold about 16.55% of the company’s shares, while institutions hold 96.63% stake in the company. Shares short for PGNY as of 1763078400 were 6677676 with a Short Ratio of 4.28, compared to 1760486400 on 6564210. Therefore, it implies a Short% of Shares Outstanding of 6677676 and a Short% of Float of 10.7.
